396 related articles for article (PubMed ID: 19741479)
21. Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis.
Krishnan S; Schouten JT; Jacobson DL; Benson CA; Collier AC; Koletar SL; Santana J; Sattler FR; Mitsuyasu R;
Oncology; 2011; 80(1-2):42-9. PubMed ID: 21606663
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study.
Nagata N; Nishijima T; Niikura R; Yokoyama T; Matsushita Y; Watanabe K; Teruya K; Kikuchi Y; Akiyama J; Yanase M; Uemura N; Oka S; Gatanaga H
BMC Cancer; 2018 Nov; 18(1):1066. PubMed ID: 30400779
[TBL] [Abstract][Full Text] [Related]
23. Non-AIDS-defining cancers among HIV-infected people.
Pinzone MR; Fiorica F; Di Rosa M; Malaguarnera G; Malaguarnera L; Cacopardo B; Zanghì G; Nunnari G
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1377-88. PubMed ID: 23104654
[TBL] [Abstract][Full Text] [Related]
24. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.
Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M
AIDS; 2010 Jul; 24(11):1765-70. PubMed ID: 20453630
[TBL] [Abstract][Full Text] [Related]
25. Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012.
Park LS; Tate JP; Sigel K; Rimland D; Crothers K; Gibert C; Rodriguez-Barradas MC; Goetz MB; Bedimo RJ; Brown ST; Justice AC; Dubrow R
AIDS; 2016 Jul; 30(11):1795-806. PubMed ID: 27064994
[TBL] [Abstract][Full Text] [Related]
26. Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study.
Park LS; Tate JP; Sigel K; Brown ST; Crothers K; Gibert C; Goetz MB; Rimland D; Rodriguez-Barradas MC; Bedimo RJ; Justice AC; Dubrow R
Ann Intern Med; 2018 Jul; 169(2):87-96. PubMed ID: 29893768
[TBL] [Abstract][Full Text] [Related]
27. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.
Achenbach CJ; Cole SR; Kitahata MM; Casper C; Willig JH; Mugavero MJ; Saag MS
AIDS; 2011 Mar; 25(5):691-700. PubMed ID: 21160411
[TBL] [Abstract][Full Text] [Related]
28. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
29. Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009.
Chen M; Jen I; Chen YH; Lin MW; Bhatia K; Sharp GB; Law MG; Arthur Chen YM
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):463-72. PubMed ID: 24583616
[TBL] [Abstract][Full Text] [Related]
30. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
31. Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.
Bedimo RJ; McGinnis KA; Dunlap M; Rodriguez-Barradas MC; Justice AC
J Acquir Immune Defic Syndr; 2009 Oct; 52(2):203-8. PubMed ID: 19617846
[TBL] [Abstract][Full Text] [Related]
32. Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.
Bruyand M; Ryom L; Shepherd L; Fatkenheuer G; Grulich A; Reiss P; de Wit S; D Arminio Monforte A; Furrer H; Pradier C; Lundgren J; Sabin C;
J Acquir Immune Defic Syndr; 2015 Apr; 68(5):568-77. PubMed ID: 25763785
[TBL] [Abstract][Full Text] [Related]
33. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.
Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ
JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773
[TBL] [Abstract][Full Text] [Related]
34. Cancer burden in the HIV-infected population in the United States.
Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous malignancies among HIV-infected persons.
Crum-Cianflone N; Hullsiek KH; Satter E; Marconi V; Weintrob A; Ganesan A; Barthel RV; Fraser S; Agan BK
Arch Intern Med; 2009 Jun; 169(12):1130-8. PubMed ID: 19546414
[TBL] [Abstract][Full Text] [Related]
36. Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012.
Wong IKJ; Grulich AE; Poynten IM; Polizzotto MN; van Leeuwen MT; Amin J; McGregor S; Law M; Templeton DJ; Vajdic CM; Jin F
HIV Med; 2022 Feb; 23(2):134-145. PubMed ID: 34585487
[TBL] [Abstract][Full Text] [Related]
37. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
38. Differences in survival according to malignancy type and degree of immunodeficiency in HIV-infected patients.
Fernández-Ruiz A; Sanjoaquín-Conde I; Letona-Carbajo S; Lambea-Sorrosal JJ; Crusells-Canales MJ
Med Clin (Barc); 2020 Apr; 154(8):295-300. PubMed ID: 31471061
[TBL] [Abstract][Full Text] [Related]
39. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.
Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; De Wit S; Phillips A; Lundgren JD; Sabin CA;
BMC Infect Dis; 2013 Oct; 13():471. PubMed ID: 24106926
[TBL] [Abstract][Full Text] [Related]
40. Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study.
Raffetti E; Albini L; Gotti D; Segala D; Maggiolo F; di Filippo E; Saracino A; Ladisa N; Lapadula G; Fornabaio C; Castelnuovo F; Casari S; Fabbiani M; Pierotti P; Donato F; Quiros-Roldan E;
BMC Public Health; 2015 Mar; 15():235. PubMed ID: 25884678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
